Concepedia

David Alkalai

DA

Statistics

Publications

4

Citations

183

H-Index

4

Active since

1992

Affiliations

Israel Institute for Biological Research(Current)

David Alkalai is an author at Israel Institute for Biological Research specializing in medicine, neuroscience, and neuropharmacology.

Top concepts

MedicineNeuroscienceNeurologyPharmacologyNeurochemistryPharmacotherapySocial SciencesNeuropharmacologyCentral Nervous SystemToxicology

Publications per year

1992–2002

4

Publications

4

Long-Term Study of Brain Lesions Following Soman, in Comparison to DFP and Metrazol Poisoning

Tamar Kadar, Giora Cohen, Rita Sahar et al. · Human & Experimental Toxicology · 1992 · 68 citations

Pharmacotherapy, Brain Lesion, Acute Lethal +17

Stress Does Not Enable Pyridostigmine to Inhibit Brain Cholinesterase after Parenteral Administration

Ettie Grauer, David Alkalai, Joseph Kapon et al. · Toxicology and Applied Pharmacology · 2000 · 64 citations

Enable Pyridostigmine, Neuropsychology, Inhibit Brain Cholinesterase +9

Nasal midazolam as a novel anticonvulsive treatment against organophosphate-induced seizure activity in the guinea pig

Eran Gilat, Michaël Goldman, Eli Lahat et al. · Archives of Toxicology · 2002 · 27 citations

Organophosphate-induced Seizure Activity, Neurophysiology, Medicine +10

Prophylaxis against organophosphate poisoning by sustained release of scopolamine and physostigmine

Yacov Meshulam, Giora Cohen, Shira Chapman et al. · Journal of Applied Toxicology · 2001 · 24 citations

1–4 of 4